Employees: 02 (2023.0)Legal category: 5202Size: PMECreation date: 1988-10-04 (37 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ITEUIL (86240), Vienne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE SILLAS-GUILLEMAIN : revenue, balance sheet and financial ratios
PHARMACIE SILLAS-GUILLEMAIN is a French company
founded 37 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ITEUIL (86240),
this company of category PME
shows in 2024 a net income positive of 40 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE SILLAS-GUILLEMAIN (SIREN 348828765)
Indicator
2024
2022
Revenue
N/C
N/C
Net income
40 300 €
20 011 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE SILLAS-GUILLEMAIN generates positive net income of 40 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2024: 20 k€ -> 40 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
40 300 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 44%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
44.163%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
60.561%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2022
2024
Debt ratio
45.226
44.163
Financial autonomy
61.81
60.561
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
44.162024
2022
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Good+6 pts over 2 years
In 2024, the debt ratio of PHARMACIE SILLAS-GUILLEMAIN (44.16) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
60.56%2024
2022
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good-5 pts over 2 years
In 2024, the financial autonomy of PHARMACIE SILLAS-GUILLEMAIN (60.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 307.69. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2022
2024
Liquidity ratio
315.777
307.687
Interest coverage
None
None
Sector positioning
Liquidity ratio
307.692024
2022
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of PHARMACIE SILLAS-GUILLEMAIN (307.69) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE SILLAS-GUILLEMAIN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE SILLAS-GUILLEMAIN is estimated at
562 617 €
(range 391 798€ - 841 708€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
391k€562k€841k€
562 617 €Range: 391 798€ - 841 708€
NAF 5 année 2024
Valuation method used
Net Income Multiple
40 300 €
×
14.0x
=562 618 €
Range: 391 798€ - 841 708€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE SILLAS-GUILLEMAIN with other companies in the same sector:
Frequently asked questions about PHARMACIE SILLAS-GUILLEMAIN
What is the revenue of PHARMACIE SILLAS-GUILLEMAIN ?
The revenue of PHARMACIE SILLAS-GUILLEMAIN is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE SILLAS-GUILLEMAIN profitable?
Yes, PHARMACIE SILLAS-GUILLEMAIN generated a net profit of 40 k€ in 2024.
Where is the headquarters of PHARMACIE SILLAS-GUILLEMAIN ?
The headquarters of PHARMACIE SILLAS-GUILLEMAIN is located in ITEUIL (86240), in the department Vienne.
Where to find the tax return of PHARMACIE SILLAS-GUILLEMAIN ?
The tax return of PHARMACIE SILLAS-GUILLEMAIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE SILLAS-GUILLEMAIN operate?
PHARMACIE SILLAS-GUILLEMAIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart